Skip to content

Clinical trials

Completed Hyperbilirubinemia, Neonatal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperbilirubinemia, Neonatal Status: Completed Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20084
20091
20103
20112
20122
20135
20141
20152
20163
20171
20185
20193
20203
20213
20223
20233
20248
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company3
Nanjing Medical University3
University of Aarhus3
University of Oxford3
Karabuk University2
St. Olavs Hospital2
University of Minnesota2
University of Patras2
Ain Shams University1
Alexandria University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperbilirubinemia, Neonatal55
Hyperbilirubinemia18
Jaundice, Neonatal15
Jaundice5
Premature Birth4
Disease2
Anemia, Neonatal1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1
Glucosephosphate Dehydrogenase Deficiency1
Infant, Newborn, Diseases1

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.